Audiometry identifies genetic loci linked to hearing loss
-
By
-
Andrea Surnit
-
November 13, 2026
-
5 min
By
Andrea Surnit
November 13, 2026
Phase 3 SURPASS ET data showed higher durable response rates with ropeginterferon alfa-2b-njft than with anagrelide.
September 1, 2026
Combining IL-17 with TNF-alpha showed strong discrimination between carious lesions and healthy controls, but performance was more modest against gingival inflammation.
September 9, 2026
A needle goes missing, tea spills secrets, cells age, and dinner serves up a surprise this week.
by Teraya Smith
November 5, 2026